FDA Inspection 738711 — Shandong Qilu King-phar Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Qilu King-phar Pharmaceutical Co., Ltd. on August 4, 2011 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 4, 2011
- Fiscal Year
- 2011
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Jinan (China)